Defunct Company
Total Trials
5
As Lead Sponsor
As Collaborator
0
Total Enrollment
1,092
NCT03691844
AMZ001 for the Treatment of Knee Osteoarthritis Symptoms
Phase: Phase 2/3
Role: Lead Sponsor
Start: Oct 4, 2018
Completion: Jul 9, 2019
NCT05128344
A Study to Evaluate Safety and Efficacy of AMZ002 Treatment, Compared With Vigabatrin in Participants With Infantile Spasms
Phase: Phase 3
Start: Apr 30, 2023
Completion: Dec 31, 2025
NCT05968482
Bioavailability and Safety Study Comparing Two Dose Levels of AMZ001 and One Dose Level of Diclofenac Sodium 1% Gel in Healthy Participants
Phase: Phase 1
Start: Jul 11, 2023
Completion: Dec 2, 2024
NCT06729073
Comparison of Diclofenac Systemic Exposure From Two Different Products (AMZ001 and Diclofenac Diethylammonium 1.16% Gel) in Healthy Participants After Repeated Topical Administrations for 7 Days.
Start: Nov 29, 2024
Completion: Jul 31, 2025
NCT06693648
A Study to Evaluate Efficacy and Safety of AMZ001 for the Treatment of Knee Osteoarthritis Symptoms
Start: Feb 18, 2025
Completion: Mar 31, 2026